Patents
Patents for C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
11/2007
11/29/2007WO2007136680A2 3-pyraz0lyl-benzamide-4-ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
11/29/2007WO2007134799A1 Novel microbiocides
11/29/2007US20070276028 Pesticidal n-phenylpyrazole derivatives
11/29/2007CA2650795A1 Novel microbiocides
11/29/2007CA2646076A1 3-pyraz0lyl-benzamide-4-ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
11/21/2007CN101076525A Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha
11/21/2007CN101074228A Method for preparing medicine composition containing 1,3-oxathin cyclopentane nucleoside analogues
11/20/2007US7297797 5-(2,6-difluorophenyl)-2-[4'-(5-ethoxy-2-thienyl)-1,1'-biphenyl-4-yl]-3,4-dihydro-2H-pyrrole; pesticide
11/15/2007WO2007099323A3 Quinoline derivatives
11/07/2007CN101066971A Non-enantioselective prepn process of emtricitabine
11/07/2007CN101066970A Method for preparing medicine composition containing 1,3 oxathiolane nucleoside analogue
10/2007
10/31/2007EP1848692A1 AZOLYLACYLGUANIDINES AS ß-SECRETASE INHIBITORS
10/31/2007EP1848435A2 Compounds for inflammation and immune-related uses
10/31/2007CN100345552C Enantiomerically pure beta-d-dioxolane nucleosides with selective anti-hepatitus b virus activity
10/30/2007US7288652 Method for preparing oltipraz
10/30/2007CA2340214C Method of manufacture of 1,3-oxathiolane nucleosides
10/25/2007WO2007120729A2 Pyridyl amide t-type calcium channel antagonists
10/25/2007WO2007119248A1 A novel crystalline form of lamivudine
10/25/2007US20070249598 selective antagonists of A2B adenosine receptors; for improving insulin sensitivity; asthma
10/25/2007CA2649796A1 A novel crystalline form of lamivudine
10/24/2007CN101061112A (Spirocyclylamido) aminothiophene compounds as c-Kit proto-oncogene inhibitors
10/24/2007CN101061096A Cycloalkyl keto piperidine tachykinin receptor antagonists
10/24/2007CN101061095A Cycloalkyl piperidine tachykinin receptor antagonists
10/24/2007CN100344623C Acrylic esters compound and use thereof
10/18/2007US20070244130 Compounds and Compositions as Ppar Modulators
10/17/2007CN100343238C Quinazoline derivatives as antitumor agents
10/11/2007WO2007077505A3 Crystalline l-menthyl (2r, 5s)-5-(4-amino-5-fluoro-2-oxo-2h-pyrimidin-1-yl)[1, 3]oxathiolan-2-carboxylate and process for preparation thereof
10/11/2007US20070238738 Crystalline ziprasidone HCI and processes for preparation thereof
10/11/2007US20070238729 Dna-pk inhibitors
10/10/2007CN101052301A (hetero) cyclylcarboxamide for preventing and controlling pathogenic fungi
10/04/2007US20070232655 2-Pyridinylcycloalkylcarboxamide Derivatives Useful as Fungicides
10/03/2007EP1599468B1 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
10/02/2007CA2283242C Pesticidal 1-arylpyrazoles
10/02/2007CA2160912C 3-(het)arylcarboxylic acid derivatives, their preparation and intermediates for their preparation
09/2007
09/27/2007WO2007107965A1 Cyclohexyl or piperidinyl carboxamide antibiotic derivatives
09/26/2007CN100339375C Metabolites of ecteinascidin 743
09/19/2007EP1740544B1 2-pyridinylcycloalkylcarboxamide derivatives useful as fungicides
09/13/2007US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/05/2007EP1829865A2 Chemical compounds
09/05/2007EP1828169A2 Urea inhibitors of map kinases
09/05/2007EP1828155A2 Diuretic compounds comprising heterocyclic nitric oxide donor groups,compositions and methods of use
09/05/2007EP1828127A2 INSECTICIDAL BIS(SUBSTITUTED PHENYL)-1-äÝ4-(SATURATED HETEROCYCLYL-SUBSTITUTED)PHENYLMETHYL¨-(4-PIPERIDYL)üMETHANE DERIVATIVES
09/05/2007EP1388540B1 Acrylic esters and use thereof
08/2007
08/29/2007EP1826209A1 Nitromethylene derivatives and their use
08/29/2007EP1824845A1 1-arylpyrazoles and their use as pesticides
08/29/2007EP1824843A2 Inhibitors of protein kinases
08/22/2007CN1332950C Improved compounds for generating chemiluminescence with peroxidase
08/21/2007CA2099589C Enantiomerically pure .beta.-d-(-)-dioxolane-nucleosides
08/16/2007WO2007091753A1 Method for resolving enantiomers from racemic mixture having chiral carbon in alpha position of nitrogen
08/16/2007US20070191426 Derivatives of 3-aminocarbonylquinoline, pharmaceutical compositions containing them and processes and intermediates for their preparation
08/15/2007EP1817310A1 (spirocyclylamido) aminothiophene compounds as c-kit proto-oncogene inhibitors
08/15/2007EP1817285A2 Cycloalkyl keto piperidine tachykinin receptor antagonists
08/08/2007CN101014574A Hiv整合酶抑制剂 Hiv integrase inhibitors
08/07/2007CA2302943C Phthalazine compounds and therapeutic agents for erectile dysfunction
08/07/2007CA2247734C New piperazine and piperidine compounds selectively binding dopamine and serotonin receptors
08/02/2007WO2006081391A3 Compounds for inflammation and immune-related uses
08/01/2007EP1812419A2 Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha
07/2007
07/25/2007EP1809301A2 Preparation of 2'fluoro-2'-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
07/24/2007US7247726 Generating chemiluminescence by reaction with peroxidase compound and detection of signal with analyzing compound
07/19/2007US20070167493 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation, therapeutic and cosmetic uses thereof
07/18/2007EP1808434A2 Use of 5-fluoro-2'-deoxy-3'-thiacytidine fo the treatment of hepatitis B
07/17/2007US7244722 5-HT2A receptor related disorders; such as 1-(2-(2-fluoro-4-nitrophenoxy)ethyl)-3-(1piperazinyl)-2(1H)-pyrazinone
07/12/2007WO2007077505A2 Crystalline l-menthyl (2r, 5s)-5-(4-amino-5-fluoro-2-oxo-2h-pyrimidin-1-yl)[1, 3]oxathiolan-2-carboxylate and process for preparation thereof
07/11/2007CN1995022A Process for the synthesis of nucleoside analogues
07/03/2007CA2188306C Process for the diastereoselective synthesis of nucleoside analogues
06/2007
06/28/2007US20070149547 Bipyridyl amides as modulators of metabotropic glutamate receptor-5
06/27/2007EP1480955B1 O-cyclopropyl-carboxanilides and their use as fungicides
06/27/2007EP1343779B1 Novel compounds
06/26/2007US7235544 for use in conjunction with thrombolytic agents, thus permitting the use of a lower dose of thrombolytic agent; treatment of acute vascular diseases; may have potential in neurogenerative diseases such as Parkinson's and Alzheimer's disease
06/14/2007US20070135502 Heterocyclic compounds and methods of use
06/13/2007EP1794137A2 Specific kinase inhibitors
06/12/2007US7230100 Having a predominantly cis configuration by coupling an S-oxide of a 2-oxymethyl- thiolane, dithiolane or oxathiolane with a nucleoside base in the presence of a tertiary amine, a Lewis acid of a Group 1B or 2B metal catalyst and deprotecting the intermediate formed
06/12/2007US7230098 2-amino- pyridines and pyrazines additionally substituted witn one or more carbocyclic or heterocyclic groups, e.g., 4-[6-amino-5-(2,6-dichloro-benzyloxy)-pyridin-3-yl]-phenol, for treating many kinds of cancer
06/12/2007US7230023 Triazole compound containing a phosphonate group
06/06/2007EP1791427A1 (hetero)cyclylcarboxamides for controlling pathogenic fungi
06/05/2007US7226918 DNA-PK inhibitors
05/2007
05/29/2007US7223777 Such as 1-(2-thien-2'-yl- 2-oxoethyl)-3-((3-phenylmethyl) pyrazol-5-yl)pyridinium bromide for treating diseases caused by the accumulation of AGE (Advanced Glycation Endproducts); antidiabetic/ antiaging agents
05/24/2007US20070117845 2-Pyridinylethylcarboxamide derivatives and their use as fungicides
05/15/2007US7217723 Heterocyclic compound having oxime group
05/10/2007WO2007053506A1 Aspartyl protease inhibitors
05/10/2007US20070105905 Novel macrocycles for the treatment of cancer
05/10/2007CA2628264A1 Aspartyl protease inhibitors
05/03/2007WO2007049798A1 Novel benzoxathiin derivative
05/03/2007CA2627139A1 Novel benzoxathiin derivative
05/02/2007CN1955177A LAM nucleoside derivate, its preparation method and application
05/02/2007CN1955164A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
04/2007
04/26/2007WO2007045877A1 4-heteroarymethyl substituted phthalazinone derivatives
04/26/2007CA2623703A1 4-heteroarylmethyl substituted phthalazinone derivatives
04/19/2007US20070088044 Quinazoline derivatives as antitumor agents
04/12/2007US20070082921 Quinazoline derivatives as antitumor agents
04/11/2007EP1772151A2 Method and compositions for the synthesis of bch-189 and related compounds
04/11/2007CN1946695A 2-pyridinylcycloalkylcarboxamide derivatives useful as fungicides
03/2007
03/29/2007US20070072874 Aminoheteroaryl compounds as protein kinase inhibitors
03/28/2007CN1938273A Tetrahydrocarbazoles and derivatives
03/28/2007CN1938031A Biaryl substituted pyrazinones as sodium channel blockers
03/22/2007US20070066652 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
03/22/2007US20070066575 Methods and compositions for mitigating pain
03/21/2007CN1933838A Bipyridyl amides as modulators of metabotropic glutamate receptor-5
03/21/2007CN1305871C Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders
03/14/2007EP1761500A1 Pesticidal n-phenylpyrazole derivatives
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 25